Form Name | Baseline | 6 months | 12 months | 18 months | 24 months | 30 months | 36 months | 42 months | 48 months | 54 months | 60 months |
---|---|---|---|---|---|---|---|---|---|---|---|
Adverse Events | As needed | ||||||||||
Behavioral History | |||||||||||
Blood Collection Form | |||||||||||
Change in Diagnosis | As needed | ||||||||||
CSF Collection Data Form | When CSF collected | ||||||||||
CSF Collection Follow Up Phone Call | Within 72 hours of collection | ||||||||||
Demographics | |||||||||||
Early Termination Questionnaire | As needed | ||||||||||
Epworth Sleepiness Scale | |||||||||||
Family History | |||||||||||
Hamilton Anxiety Rating Scale (HAM-A) | |||||||||||
Hamilton Depression Rating Scale (HDRS) | |||||||||||
Informed Consent and Enrollment | |||||||||||
Laboratory Tests and Tracking | Not required; should be used when laboratory testing is performed and when LP is taken. Investigators can choose to do standard blood analysis at the baseline visit and prior to LP. | ||||||||||
Mayo Fluctuation Scale | As needed | ||||||||||
MDS-UPDRS (Movement Disorder Society - Unified Parkinson's Disease Rating Scale) | |||||||||||
Modified Schwab and England Activities of Daily Living Scale | |||||||||||
Montreal Cognitive Assessment (MoCA)7_1 | |||||||||||
NACC Neuropathology | As needed | ||||||||||
Neurological Exam | |||||||||||
Parkinsonism Medications | As needed | ||||||||||
PDBP LBD Inclusion and Exclusion Criteria | |||||||||||
PDBP Sample Record Summary & Shipment Notification | When samples are collected and shipped | ||||||||||
PDBP Special Attributes | As needed | ||||||||||
PDQ-39 | |||||||||||
Prior and Concomitant Medications | |||||||||||
Protocol Deviations | As needed | ||||||||||
Rapid Eye Movement Behavior Disorder Questionnaire | |||||||||||
University of Pennsylvania Smell Identification Test (UPSIT) | |||||||||||
Vital Signs |